4 ms·
"We" as in the readers here. We all know the basics around how cancer research is hard and how getting new drugs through trials takes time and money. Did you k
by user43928 2mo ago
"We" as in the readers here. We all know the basics around how cancer research is hard and how getting new drugs through trials takes time and money.
Did you know that Amodei was working on research about cancer biomarkers at Stanford?
Given his background in biology, it is hardly like he is a random tech guy with no knowledge on the topic, as many here seem to imply.
Amodei mentioned "actually curing cancer" as an example of undeniable public benefit, not as an exclusive research focus or anything like that. He is clearly talking about generally intensifying biomedical efforts, not promising a cure for cancer specifically.